

Levomilnacipran XR (Fetzima) is an SNRI antidepressant for major depression. Learn about its uses, dosing, cost, and what makes it different in 2026.
Levomilnacipran XR is an extended-release prescription medication used to treat major depressive disorder (MDD) in adults. It belongs to a class of drugs called serotonin-norepinephrine reuptake inhibitors (SNRIs) and is sold under the brand name Fetzima.
Originally developed by Forest Laboratories and Pierre Fabre Group, it is now manufactured by AbbVie Inc. The FDA approved Fetzima in 2013, making it one of the newer SNRIs on the market. Levomilnacipran XR is not a controlled substance.
Levomilnacipran XR is FDA-approved for one indication:
MDD is more than just feeling sad. It's a persistent condition that affects your mood, energy, sleep, appetite, and ability to function for at least two weeks. Levomilnacipran XR is typically prescribed when other antidepressants — like SSRIs — haven't provided adequate relief, especially when fatigue, low motivation, and difficulty concentrating are prominent symptoms.
Some doctors also prescribe Levomilnacipran XR off-label for anxiety disorders, neuropathic pain, and chronic fatigue associated with depression, though the evidence for these uses is more limited.
While Levomilnacipran XR belongs to the same drug class as Duloxetine (Cymbalta), Venlafaxine XR (Effexor XR), and Desvenlafaxine (Pristiq), it has a key difference: it has roughly 15 times greater selectivity for norepinephrine reuptake inhibition compared to serotonin. Other SNRIs are more serotonin-dominant.
This means Levomilnacipran XR may be particularly helpful for patients whose depression features prominent fatigue, low energy, poor concentration, and lack of motivation — symptoms more closely linked to norepinephrine. Learn more in our guide on how Levomilnacipran XR works.
Levomilnacipran XR comes as extended-release capsules in four strengths:
Because Levomilnacipran XR is cleared through the kidneys, patients with renal impairment need lower doses:
No dose adjustment is needed for liver problems.
Levomilnacipran XR is not appropriate for everyone. You should not take it if you:
You should use caution and discuss with your doctor if you have:
Levomilnacipran XR is not approved for children or adolescents. It carries an FDA boxed warning about increased risk of suicidal thoughts in young adults (ages 18-24). For more on side effects, see our complete side effects guide.
The cost of Levomilnacipran XR depends on whether you're getting brand-name or generic, and whether you have insurance:
For a full breakdown of savings options, see our guide on how to save money on Levomilnacipran XR.
Levomilnacipran XR is a unique SNRI that offers a norepinephrine-focused approach to treating major depression. It's a solid option for patients who haven't responded to SSRIs or other SNRIs, particularly those struggling with fatigue, low motivation, and difficulty concentrating.
While it's generally well-tolerated, it's not the cheapest antidepressant on the market — and it may require some effort to find in stock at your local pharmacy. If you need help locating Levomilnacipran XR or finding the best price, Medfinder can help.
Always work with your doctor to determine if Levomilnacipran XR is the right choice for your specific situation.
You focus on staying healthy. We'll handle the rest.
Try Medfinder Concierge FreeMedfinder's mission is to ensure every patient gets access to the medications they need. We believe this begins with trustworthy information. Our core values guide everything we do, including the standards that shape the accuracy, transparency, and quality of our content. We’re committed to delivering information that’s evidence-based, regularly updated, and easy to understand. For more details on our editorial process, see here.